Nextech Invest is a venture capital firm based in Zurich, Switzerland focused on fueling the success of emerging biotechnology companies worldwide. Their investment strategy centers around identifying transformative cancer medicines and nurturing their portfolio companies through critical phases of scientific validation and value creation. They aim to be a sought-after partner for innovators by providing rigorous scientific due diligence and hands-on support for company development. They believe in deeply understanding precision medicines to gain unique insights and differentiate portfolio companies from their competition. Their focus is on making a significant impact for both patients and investors by overcoming resistance in cancer.
Preferred startup development maturity for initial funding deployment.
Precision medicine, Cancer therapeutics, Oncology, Biotechnology
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...